Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000250 · ClinicalTrials.gov registry record · Phase 2
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
A Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00000250: Completed Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders, sponsored by University of Chicago.
NCT00000250 is a Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders that has completed, run by University of Chicago. The registered enrollment target is 12 participants, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000250, a Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate: cold water immersion modulates the reinforcing effects of nitrous oxide in healthy volunteers.
Conditions Studied
Interventions
- DRUG 0% N2O
- DRUG 40% N2O
Study Locations (1)
Illinois
- University of Chicago, Anesthesia & Critical Care - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 1993-12 |
| Est. Completion | 1995-05 |
| Phase | Phase 2 |
What the finished NCT00000250 record still lists
NCT00000250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which 0% N2O is the first listed.
NCT00000250 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00000250 about?
NCT00000250 is a clinical study titled "Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2". The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate: cold water immersion modulat...
What is the current status of trial NCT00000250?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 1993-12. Estimated completion is 1995-05.
What conditions does trial NCT00000250 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Opioid-Related Disorders.
What interventions are being tested in trial NCT00000250?
The interventions under investigation include: 0% N2O (DRUG), 40% N2O (DRUG).
Who is sponsoring clinical trial NCT00000250?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000250 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00000250's enrollment target sits among peer trials
12 56th of 58 higher than 2 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
RECRUITING · Phase 2
-
GLP-1R Agonist Treatment for Opioid Use Disorder
RECRUITING · Phase 2
-
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
COMPLETED · Phase 2
-
Buprenorphine Maintenance for Opiate Dependence - 6
COMPLETED · Phase 2
-
A Laboratory Model for Heroin Abuse Medications - 8
COMPLETED · Phase 2
-
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia